Clinicopathological aspects of parkinson’s disease

European Neurology

Volumn 38, Issue , 1997, Pages 13-20

  Hughes, A J ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Clinicopathological studies; Dementia with Lewy bodies; Parkinsonian syndromes; Parkinson s disease

Indexed keywords

CONFERENCE PAPER; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; HUMAN; NEOCORTEX; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL;

BRAIN; CEREBRAL CORTEX; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODIES; PARKINSON DISEASE; TERMINOLOGY;

EID: 0030724908     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000113471     Document Type: Article

References (61)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ: The accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study, J Neurol Ncurosurg Psychiatry 1992:55:1 81-184.
2. Litvan I, Mangone CA, McKee A, Vcniy M, Parsa A, Jcllingcr K, D'Olhaberriaguc L, Ray Chaudhuri K, Pearce RKB: Natural history of progressive supranuclear palsy (Steele-Ri-chardson-Olszewski syndrome) and clinical predictors of survival: A clinicopathological study, J Neurol Ncurosurg Psychiatry 1996:61: 615-620.
3. Wenning C, Ben-Shtomo Y, Magalhaes M, Daniel SE, Quinn NP: Clinicopathological study of 35 cases of multiple system atrophy, J Neurol Ncurosurg Psychiatry 1995:58:160-166.
4. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP: Clinical features and natural history of multiple system atrophy, An analysis of 100 cases, Brain 1994:117:835- 845.
5. Litvan I, Agid Y, Caine D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbc LI, Gralnian J, Growden JH, Hallet M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Stcele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop, Neurology 1996:47:1-9.
6. Litvan I, Agid Y, Jankovic J, Goetz CG, Brande! JP, Lai EC, Wenning G, D'Olhalberriague L, Vcmy M, Rav Chaudhuti K, McKee A, Jcl-lingcr K, Bartko J J, Mangone CA, Pearce RKB: Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Stcele-Ri-chardson-Olszewski syndrome), Neurology 1996:46:922-930.
7. Daniel SE, de Bruin VMS, Lees AJ: The clinical and pathological spectrum of Steele-Ri-chardson-Olszewski syndrome (progressive supranuclear palsy): A reappraisal, Brain 1995: 118:759-770.
8. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM: Progressive supranuclear palsy: Ncuropa-thologicallv based diagnostic criteria, J Neurol Ncurosurg Psychiatry 1995:58:167-173.
9. Rajput AH, Rozdilsky B, Rajput A: Accuracy of clinical diagnosis of parkinsonism, A prospective study, Can J Neurol Sci 1991:18:275-278.
10. Jcllingcr KA: The neuropathologic diagnosis of secondary parkinsonian syndromes; in Battis-tin L, Scarlato G, Caraccni T, Ruggieri S (eds): Parkinson's Disease, Advances in Neurology, Philadelphia, Lippincott-Ravcn Press, 1996. vol 69. pp 293-303.
11. Hughes AJ, Bcn-Shlomo Y, Daniel SE, Lees AJ: What clinical features improve the diagnosis of Parkinson's disease? Neurology 1992:42: 1142-1146.
12. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy, Arch Neurol 1964; 10:333-359.
13. Gearing M, Olson DA, Watts RL, Mirra SS: Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity, Neurology 1994:44:1015-1024.
14. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ, Stem GM: The dopaminergic response in multiple system atrophy, J Neurol Neurosurg Psychiatry 1992;55:1009-1013.
15. Ilauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I: Preliminary N1NDS neuropalho-logical criteria for Steclc-Richardson-Olszcw-ski syndrome (progressive supranuclear palsy), Neurology 1994:44:2015-2019.
16. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Banchcr C, Tabaton M, Jellinger K, Anderson EW: Validity and reliability of the preliminary N1NDS neuropathologic criteria for progressive supranuclear palsy and related disorders, J Neuropathol Exp Neurol 1996:55:97-105.
17. Verity M, Duvckacrts C, Agid Y, Hauw JJ: The significance of cortical pathology in progressive supranuclear palsy, Brain 1996; 119:1123-1136.
18. Revcsz T, Sangha H, Daniel SE: The nucleus raphe intcrpositus in the Stcele-Richardson-Olszewski syndrome (progressive supranuclear palsy), Brain 1996:119:1137-1143.
19. Quinn N: Multiple system atrophy: The nature of the beast, J Neurol Neurosurg Psychiatry 1989:52(suppl):78-89.
20. Lantos P, Papp MI: Cellular pathology of multiple system atrophy: A review, J Neurol Neurosurg Psychiatry 1994:57:129-133.
21. Albanese A, Colosimo C, Bentivoglio AR, Fe-nici R, Mclillo G, Colosimo C, Tonali P: Multiple system atrophy presenting as parkinsonism: Clinical features and diagnostic criteria, J Neurol Ncurosurg Psychiatry 1995:59:144-151.
22. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ: Some specific clinical features differentiate multiple system atrophy (striaton-igral variety) from Parkinson's disease, Arch Neurol 1995:52:294-298.
23. Tison F, Wcnning GK, Quinn NP, Smith SJ: REM sleep behaviour disorder as the presenting symptom of multiple system atrophy, J Neurol Ncurosurg Psychiatrv 1995:58:379-380.
24. Rcbciz JJ, Kolodny EH, Richardson EP: Corti-coder, tatonigral degeneration with neuronal achromasia, Arch Neurol 1968:18:20-33.
25. Riley DE, Lang AE, Lewis A, Resell L, Ashby P, Homykicwicz O, Black S: Cortical-basal ganglionic degeneration, Neurology 1990:40: 1203-1212.
26. Rinne JO, Lee MS, Thompson PD, Marsdcn CD: Corticobasal degeneration: A clinical study of 36 cases, Brain 1994:117:1183-1196.
27. Pillor, B, Blin J, Vidailhet M, Dewcer B, Sirigu A, Dubois B, Agid Y: The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer's disease, Neurology 1995:45:1477-1483.
28. Riley DE, Lang AE: Cortical-basal ganglionic degeneration; in Stem MB, Kollcr WC (eds): Parkinsonian Syndromes, New York, Dekker, 1993. pp 379-392.
29. Gibb WR, Luthcrt PJ, Marsden CD, Corticobasal degeneration, Brain 1989:112:1171-1192.
30. Jendroska K, Rossor M, Mathias C, Daniel S: Morphological overlap between corticobasal degeneration and Pick's disease: A clinieopa-thological report, Mov Disord 1995; 10:111 - 114.
31. Feany MB, Maltiace LA, Dickson DW: Neuropathologie overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration, J Ncuropathol Exp Neurol 1996;5:53-67.
32. Gibb WRG, Luthert PJ, Janota I, Lantos PL: Cortical Lewy body dementia: Clinical features and classification, J Neurol Neurosurg Psychiatry 1989;52:185-192.
33. Byme EJ, Lennox G, Lowe J, Godwin-Austin RB: Diffuse Lewy body disease: Clinical features in 15 cases, J Neurol Neurosurg Psychiatry 1989;52:709-717.
34. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Klauber M, Rice V, Butters N, Alford M: The Lewy body variant of Alzheimer’s disease: A clinical and pathologic entity, Neurology 1990; 40:1-8.
35. Perry RH, Irving D, Blessed G, Fairbaim A, Perry EK: Senile dementia of Lewy body type: A clinically and ncuropathologically distinct form of Lewy body dementia in the elderly, J Neurol Sei 1990;95:119-139.
36. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byme EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock OK, Jel-lingcr KA, Perry RH: Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies: Report of the consortium on DLB international workshop, Neurology 1996;47:1113-1124.
37. Ansorgc O, Lees AJ, Daniel SE: Update on the accuracy of clinical diagnosis of idiopathic Parkinson’s disease (abstract), Mov Disord 1997; 12(supp1 1):96.
38. Hughes AJ, Daniel SE, Blanston S, Lees AJ: The clinical features of Parkinson’s disease: A clinicopathological study of 100 cases, Arch Neurol 1993;50:140-148.
39. Brown RG, Marsden CD: How common is dementia in Parkinson’s disease? Lancet 1984:2: 1262-1265.
40. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV: Cognitive impairment in early untreated Parkinson’s disease and its relationship to motor disability, Brain 1991:114:2095-2122.
41. Caparros-Lefcbvre D, Pechcux N, Petit V, Du-hamal A, Petit H: Which factors predict cognitive decline in Parkinson’s disease? J Neurol Neurosurg Psychiatry 1995:58:51-55.
42. Stem Y, Richards M, Sano M, Maycux R: Comparison of cognitive changes in patients with Alzheimer’s and Parkinson’s disease, Arch Neurol 1993:50:1040-1045.
43. Forstl H, Bums A, Luthert P, Cairns N, Levy R: The Lewy body variant of Alzheimer’s disease: Clinical and pathologic findings, Br J Psychiatry 1993;162:385-392.
44. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austin RB: Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocvtochemisiry, J Neurol Neurosurg Psychiatry 1989:52:1236-1247.
45. Perry EK, Irving D, Kerwin J, McKeith G, Thompson P, Collerton D, Fairbaim AF, Ince PG, Morris CM, Cheng AV, Perry RH: Cholinergic transmitter and ncurotrophic activities in Lewy body dementia: similarity to Parkinson’s and distinction from Alzheimer’s disease, Alzheimer Dis Assoc Disord 1993;7:69-79.
46. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen SH: Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: Light and electron microscopic immunocyto-chemistry of CA2-3 neuritcs specific to DLBD, Neurology 1991:41:1402-1409.
47. Samuel W, Galasko D, Masliah E, Hansen L: Neocortical Lcwv body counts correlate with dementia in the Lewy body variant of Alzheimer's disease, J Neuropathol Exp Neurol 1996; 55:44-52.
48. Kosaka K: Lewy bodies in cerebral cortex, Report of three cases, Acta Neuropathol (Berl) 1978:42:127-134.
49. Kosaka K, Matsushita M, Oyanagi S, Mchraein P: A clinicopathological study of the’Lewy bodv disease', Psychiatr Neurol Jpn 1980:82: 292-311.
50. Kosaka K, Yoshimura M, Ikeda K, Budka H: Diffuse Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of various degree, A new disease? Clin Ncuropathol 1984:3:185-192.
51. Kosaka K: Diffuse Lcwv body disease in Japan, J Neurol 1990:237:197-204.
52. Gibb WRG, Ersi MM, Lees AJ: Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia), Brain 1985:110:1131-1153.
53. Louis ED, Goldman JE, Powers JM, Fahn S: Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease, Mov Disord 1995:10:188-194.
54. Mark MH, Sage JI, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC: Meigc syndrome in the spectrum of Lcwv body disease, Neurology 1994;44:1432-1436.
55. Kalra S, Bergeron C, Lang AE: Lewy body disease and dementia, Arch Intern Med 1996; 156: 487-493.
56. Galasko D, Saitah T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L: The apolipoprotcin E allele 4 is overrepresented in patients with the Lewy body variant of Alzheimer’s disease, Neurology 1994;44:1950-1951.
57. Arai H, Higuchi S, Muramatsu T, Iwatsubo T, Sasaki H, Trojanowski JQ: Apolipoprotcin E gene in diffuse Lewy body disease with or without co-existing Alzheimer’s disease, Lancet 1994;334:1307.
58. Langlais PJ, Thal L, Hansen I, Galasko D, Alford M, Masliah E: Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies, Neurology 1993:43:1927-1934.
59. McKeith I, Fairbaim A, Perry R, Thompson P, Perry E: Neuroleptic sensitivity in patients with senile dementia of Lewy bodv tvpe, BMJ 1992;305:673-678.
60. Levy R, Sahakian B: Alzheimer's disease and Lewy body dementia, Br J Psychiatry 1994: 164:268.
61. Wilcock GK, Scott M: Tacrine for senile dementia of Alzheimer’s or Lewy body type, Lancet 1994:344:544.